News and Events
VASCage has issued a press release on IMPULSE, a large clinical study, that is carried out together with Klinik Pirawarth, EVER Neuro Pharma GmbH and other VASCage scientific and company partners. Link press release (in German)
Download press picture ©Ines Schandl
Link to clinical trial IMPULSE
Decreased cognitive performance is a hallmark of brain ageing, but the underlying mechanisms and potential therapeutic avenues remain poorly understood. Now, new research results with VASCage contribution raise the intriguing possibility that dietary spermidine may be protective against cognitive decline in humans. The exciting new findings are published in the current issue of the journal Cell Reports.
Around 100 participants enjoyed the exciting talks on "Vascular Health in a Digital World" by our keynote speakers Sabine Klein (ÖGK), Winfried Ness (Helm AG) and Uwe Siebert (UMIT), the discussion with our VASCAge CSO Stefan Kiechl and the presentation of 16 project highlights! The participants also used the opportunity to network and chat in our virtual coffee area.
THANKS TO ALL OUR SPEAKERS AND PARTICIPANTS!
The word has spread within the scientific community that a new research centre on vascular ageing has started in Innsbruck. So the Dutch early-career researcher Annemieke ter Telgte came across VASCage when she was looking for an exciting new place to work abroad. She was especially attracted by the keywords stroke, epidemiology and public health, filed an application and now she is employed as a postdoc at VASCage.
A major risk factor for cardiovascular disease in young adults is overweight or obesity in adolescence. VASCage project leaders Prof. Dr. Ursula Kiechl-Kohlendorfer (Director of the Department of Paediatrics II, Division of Neonatology, Medical University of Innsbruck MUI), Assoc. Prof. Dr. Michael Knoflach (Dept. of Neurology, MUI) and her co-workers have published results that are crucial for the implementation of adequate prevention measures.
VASCage researcher Dr. Sophia Kiechl explained how life style affects our blood vessels and discussed nutrional trends with a very active audience (in German). The video is now online. The talk was part of the European Researchers' Night 2020, an event that takes place simulatenously once a year throughout Europe and invites the public to get a taste of the everyday life of research institutions.
VASCage establishes the Austrian Clinical Trial Platform Stroke (ACTstroke) as a single point of contact for international study sponsors. The aim is to enhance the attractiveness of Austria as a site for large clinical stroke trials.
The aim of the basic research study ELDERGUT is to define potential prebiotic effects of black elderberry-derived polyphenols and anthocyanins. Prebiotics serve as nutrients for beneficial microorganisms in the gastrointestinal tract.
Applied mathematics for use in medicine is cool! Nadja Gruber, mathematician at VASCage, explained to a group of girls interested in technical sciences how deep learning techniques can improve stroke image analysis.
Studies on the rehabilitation of ataxic patients are rare, especially after stroke. Now Prof. Stefan Kiechl, CSO of VASCage and Director of the Department of Neurology at the Medical University of Innsbruck, coordinates a clinical trial on ataxia after stroke.
A study of researchers at VASCage and at the Medical University of Innsbruck (MUI) on a large cohort of Tyrolean students and apprentices suggests adolescence as a prime age range for early vascular prevention. It was published in the journal Atherosclerosis.
VASCage CSO Stefan Kiechl and VASCage project leaders Ursula Kiechl-Kohlendorfer and Michael Knoflach (all Medical University Innsbruck) are among the authors of a recent Nature paper on global cholesterol trends.
A VASCage study investigates whether the attitude towards telerehabilitation has changed in physio-, occupational and in speech and language therapists in Austria, in response to the COVID-19 crisis.
The Brain Awareness Week from March 16-22 is the global campaign to foster public support for brain science. VASCage takes the opportunity to interview its Chief Scientific Officer Prof. Stefan Kiechl, who is Head of the Neurology Department at the Medical University Innsbruck.
Q: The goal of the Brain Awareness Week is to unite partners worldwide with the common theme that brain research is the hope
New publication of VASCage researchers and VASCage partners in the high-ranking Journal of the American College of Cardiology shows that the ageing of arteries progresses differently in Chinese men and women over lifetime. The findings are highly relevant for drug targeting. The publication is the result of the very fruitful cooperation between VASCage, Medical University Innsbruck, King’s College London, Zhejiang University and the Third Xiangya Hospital of Changsha, the largest medical institution in central China.
VASCage - Research Centre on Vascular Ageing and Stroke invited its partners to the first program board meeting to discuss the strategy, new projects and trends in vascular ageing and stroke together with Stefan Kiechl, VASCage CSO, and Matthias Ullrich, VASCage CEO.
The partners engaged lively in group discussions on current needs, challenges and relevant topics for future cooperation.
Thanks for coming!
VASCage GmbH is now member of the Cluster Life Sciences Tyrol and makes use of the network to facilitate cooperation. 74 highly innovative companies, institutions and universities employing more than 23,000 people make use of the Cluster Life Sciences Tyrol. Cluster Manager Petra Stöckl: ‘We are very proud to welcome with VASCage an internationally recognised COMET centre in our network!‘
Prevention of vascular ageing and stroke by early health intervention is an important research goal of VASCage. The international meeting „Addressing today’s Global Health Paradox“ in Innsbruck, initiated by Dr. Katharina Wirnitzer, University College of Teacher Education Tyrol, and Prof. Madan Thangavelu, Cambridge, UK, was a great opportunity for exchange, especially on the topics of nutrition, physical activity and targeted excercise.
Prof. Michael Brainin, President of the World Stroke Organization, gave the keynote lecture at the VASCage kickoff meeting. The Tiroler Tageszeitung used the opportunity to interview him about stroke risk factors, treatment and prognosis.
Prof. Steve Horvath of the University of California, Los Angeles, was invited by Jerome Mertens, Frank Edenhofer (both Institute of Molecular Biology, University Innsbruck) and VASCage CSO Stefan Kiechl to give a lecture on ’DNA methylation-based biomarkers and the epigenetic clock theory of ageing’ in Innsbruck.